Arun Gulani
Jacksonville, FLNPI 1902890007
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $118,495 of the $120,858 with a category attached, or 98.0%. Oculus, Inc. accounts for 96.0% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2021 at $116,279 and has fallen 99.7% since, to $318 in 2025.
Across 49 payments — averaging $2466.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Oculus, Inc.$116K
- Biotissue Holdings Inc.$3K
- Kala Pharmaceuticals, Inc.$452
- Dompe US, Inc.$339
- Alcon$313
- Johnson & Johnson Surgical Vision, Inc.$179
- plus $1K from 16 others
What the payments were for
- Consulting fees$118,49598%
- Food & beverage$2,3632%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Oculus, Inc. | 2 | $115,995 |
| Biotissue Holdings Inc. | 2 | $2,500 |
| Kala Pharmaceuticals, Inc. | 4 | $452 |
| Dompe US, Inc. | 4 | $339 |
| Alcon | 6 | $313 |
| Johnson & Johnson Surgical Vision, Inc. | 4 | $179 |
| Rxsight Inc | 2 | $177 |
| Harrow Eye, LLC | 3 | $170 |
| Tarsus Pharmaceuticals, Inc. | 2 | $132 |
| Lensar, Inc. | 1 | $102 |
| Carl Zeiss Meditec, Inc. | 2 | $95 |
| Sight Sciences, Inc. | 3 | $94 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $64 |
| Rayner Intraocular Lenses Limited | 1 | $37 |
| Bausch & Lomb Americas Inc. | 2 | $37 |
| Carl Zeiss Meditec USA, Inc. | 1 | $36 |
| Amgen | 1 | $30 |
| Sun Pharmaceutical Industries Inc. | 1 | $29 |
| Thea Pharma Inc. | 1 | $26 |
| AbbVie | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Pentacam$115,995
- Prokera$2,500
- AmnioGraft$2,500
- AmnioGuard$2,500
- INVELTYS$404
- Oxervate$223
- RXSIGHT CONTACT LENS$163
- RXSIGHT INJECTOR CARTRIDGE$163
- RXSIGHT INJECTOR HANDPIECE$163
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$163
- LIGHT ADJUSTABLE LENS (LAL)$163
- NGENUITY$144
- Luxor$144
- EYSUVIS$143
- IHEEZO$125
- XDEMVY$109
- CATALYS SYSTEM$104
- LENSAR LASER SYSTEM$102
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $26 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.